1型糖尿病合并甲状腺功能亢进症7例临床分析并文献复习被引量：1

下载PDF

导出

摘要为更好地了解甲腺功能亢进症(甲亢)合并1型糖尿病(T1DM)的临床表现、发病过程、治疗特点、转归情况,回顾分析了7例有完整病历记录的、伴发T1DM的甲亢患者的资料,发现由于两种疾病具有相同的非特异性的临床表现,易误漏诊,并且两者可以相互促进,因此有必要提高认识,减少误漏诊率,规范指导治疗。

作者孟晓军盛志新肖佐环

机构地区中山大学附属第五医院内分泌科

出处《中国实用医药》 2010年第21期178-179,共2页 China Practical Medicine

关键词甲腺功能亢进症 1型糖尿病误诊

分类号 R587.1 [医药卫生—内分泌]

引文网络
相关文献

参考文献7

1Cáp J.Thyroid orbitopathy and diabetes.Vnitr Lek.2007 May;53(5):524-7.
2Unnikrishnan AG,Kumaravel V,Nair V,Rao A,et al:TSH receptor antibodies in subjects with type 1 diabetes mellitus.Ann N Y Acad Sci,2006,1079:220-225.
3Otto-Buczkowska E,Jarosz-Chobot P,Minkina-Pedras M,et al:Coexistance of autoimmunological diseases with type 1 diabetes mellitus in young patients based on literature and own experience.Przegl Lek,2008,65(3):140-144.
4Prázn M,Skrha J,Límanová Z,Vanícková Z,et al:Screening for associated autoimmunity in type 1 diabetes mellitus with respect to diabetes control.Physiol Res,2005,54(1):41-48.
5Suzuki H,Isaka M,Suzuki S.Type 1 diabetes mellitus associated with Graves' disease and Vogt-Koyanagi-Harada syndrome.Intern Med,2008,47(13):1241-1244.
6Prázn M,Skrha J,Límanová Z,Vanícková Z,et al:Screening for associated autoimmunity in type 1 diabetes mellitus with respect to diabetes control.Physiol Res,2005,54(1):41-8.
7于红艳,刘文淑,王瑞英.甲状腺功能亢进与胰岛素原[J].国外医学（内分泌学分册）,2002,22(2):104-106. 被引量：11

二级参考文献14

1Roder M E, Dinesen B, Hartling S G, et al. Intact proinsulin and beta-cell function in lean and obese subjects with and without type 2 diabetes [J]. Diabetes Care, 1999,22:609-614.
2Pandolfi C, Pellgrini L, Dede A. Blood glucose and insulin responses to oral glucose in hyperthyroidism[J]. Minerva Endocrinol,1996,21:63-65.
3Bech K, Damsbo P, Eldrup E, et al.β3-cell function and glucose and lipid oxidation in Graves＇ disease[J].Clin Endocrinol(oxf), 1996,44:59-66.
4Mykkanen L, Zaccaro D J, Hales C N, et al. The relation of proinsulin and insulin to insulin sensitivity and acute insulin response in subjects with newly diagnosed type Ⅱ diabetes: the insulin resistance atherosclerosis study [J]. Diabetologia,1999,42:1060-1066.
5Wu T J, Huang S M, Taylor R L, et al. Abnormal proinsulin in thyroid dysfunction [J[. Ann Clin Lab Sci, 1998,13:82-87.
6Nagi D K, Knowler W C, Mohamed-Ali V, et al. Intact proinsulin, des 31, 32 proinsulin, and specific insulin concentrations among nondiabetic and diabetic subjects in populations at varying risk of type 2 diabetes[J]. Diabetes Care, 1998,21:127-133.
7Kahn S E, Halban, P A. Release of incompletely processed proinsulin is the cause of the disproportionate proinsulinemia of NIDDM[J]. Diabetes,1997,46:1725-1732.
8Roder M E, Porte D Jr, Schwartz R S, et al. Disproportionately elevated proinsulin levels reflect the degree of impaired B cell secretory capacity in patients with noninsulin -dependent diabetes mellitus[J].J Clin Endocrinol Metab,1998,83:604-608.
9Haffner S M, Gonzalez C, Mykkanen L. et al. Total immunoreactive proinsulin, immunoreactive insulin and specific insulin in relation to conversion to NID-DM: the Mexico City Diabetes Study[J]. Diabetologia,1997,40:830-837.
10Crill V, Bjorklund A. Overstimulation and beta-cell function[J]. Diabetes,2001,50:122-124.